Skip to main navigation Skip to search Skip to main content

Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer

  • Shom Goel*
  • , Ehtesham Abdi
  • , Craig R Lewis
  • , M. Links
  • , Steven Begbie
  • , P. Clingan
  • , Vinod Ganju
  • , Jane Beith
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases